Regeneron Pharmaceuticals Inc. buy Guggenheim
Start price
01.05.25
/
50%
€530.00
Target price
01.05.26
€716.36
Performance (%)
24.47%
Price
13:09
€656.10
This prediction will end soon
Summary
This prediction is currently active. The BUY prediction by Guggenheim currently has a performance of 24.47%. Dividends of €3.58 are taken into consideration when calculating the performance. This prediction currently runs until 01.05.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Regeneron Pharmaceuticals Inc. | 3.538% | 3.538% |
| iShares Core DAX® | -0.201% | 5.471% |
| iShares Nasdaq 100 | 2.573% | 10.092% |
| iShares Nikkei 225® | 0.598% | 9.871% |
| iShares S&P 500 | 1.804% | 7.404% |
Comments by Guggenheim for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its price target lowered by analysts at Guggenheim from $940.00 to $810.00. They now have a "buy" rating on the stock.
Ratings data for REGN provided by MarketBeat
Stopped prediction by Guggenheim for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€651.20
09.02.26
09.02.26
€824.85
09.02.27
09.02.27
0.54%
13:09
13:09
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€558.60
29.10.25
29.10.25
€742.60
29.10.26
29.10.26
17.37%
13:09
13:09
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€434.90
30.05.25
30.05.25
-
30.05.26
30.05.26
50.95%
13:09
13:09
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€991.00
02.08.24
02.08.24
€1,190.9
02.08.25
02.08.25
-51.34%
03.08.25
03.08.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€973.80
19.07.24
19.07.24
€1,082.5
19.07.25
19.07.25
-51.82%
20.07.25
20.07.25